Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2024-04-10 00:00:00 ET · period of report 2024-04-08 · accession 0001140361-24-019167 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-10 | 2024-04-08 | RCKT | White Mark Andrew | See Remarks | S - Sale | $24.64 | -12.5K | 75.2K | -14% | -$308.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-08 | S | D | 12,532 | $24.64 | 75,226 | D | — | — | (F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. RSUs vest one-third (1/3) upon the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments over the following two years. |